NUS researchers find new biomarkers associated with chemobrain

Biologics |  News | 0 Comment | 24 Apr, 2019

Cognitive impairment associated with cancer, also known as “chemobrain”, has gained recognition as a complication of the disease and its treatment, as it can negatively affect t...Read more

NTU researchers link bronchiectasis with allergy

Biologics |  News | 0 Comment | 22 Apr, 2019

An international research team led by Nanyang Technological University, Singapore (NTU Singapore) has found that patients with the lung disease bronchiectasis also often display sensitivity...Read more

India to be one of the world’s ‘fastest growing bio’ hubs in 2019: CPhI data

Biologics |  News | 0 Comment | 18 Apr, 2019

New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production. The India spe...Read more

Quantum dot imaging advances

Biologics |  News | 0 Comment | 17 Apr, 2019

Investigations of 'quantum dots' for looking deeply into body tissues are rapidly evolving, but more work is required to ensure they are safe, according to a review published in the journal...Read more

NUS provides new insights into neuronal behaviour

Biologics |  News | 0 Comment | 11 Apr, 2019

Dr Sajikumar Sreedharan and undergraduate student Karen Pang, PhD student Mahima Sharma, post-doctoral fellow Dr. Krishna Kumar – all from the Department of Physiology at the National...Read more

Researchers develop automated detection technique for eye surface cancer

Biologics |  News | 0 Comment | 03 Apr, 2019

A team of researchers from the Centre for Nanoscale BioPhotonics (CNBP) in Australia has developed a new automated non-invasive technique for diagnosing eye surface cancer (ocular surface s...Read more

FDA approves ASCENIV for the treatment of primary humoral immunodeficiency disease

Biologics |  News | 0 Comment | 02 Apr, 2019

ADMA Biologics, a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops plasma-derived biologics for the treat...Read more

GHIT selects joint research project on dengue by Chugai, A*STAR

Biologics |  News | 0 Comment | 02 Apr, 2019

Chugai Pharmaceutical Co., Ltd. has announced that a joint research project between Chugai and the Agency for Science, Technology and Research, Singapore (A*STAR) since 2015 for an anti-den...Read more

Scientists identify FLIP Inhibitors for cancer treatment

Biologics |  News | 0 Comment | 29 Mar, 2019

Queen’s University Belfast and Domainex are pleased to announce that their joint project team has successfully identified novel first-in-class small molecule inhibitors of the an...Read more

Duke-NUS study reveals new treatment option for liver cancer

Biologics |  News | 0 Comment | 29 Mar, 2019

Researchers from Duke-NUS Medical School, Singapore General Hospital (SGH) and Lion TCR have demonstrated that they were able to engineer HBV-specific T cells, a type of immune cells found ...Read more

Duke-NUS study shows promise for heart muscle regeneration

Biologics |  News | 0 Comment | 25 Mar, 2019

Researchers at Duke-NUS Medical School, Singapore, have developed an approach to regenerate heart muscle using stem cells. Their method for priming stem cells to become heart tissues could ...Read more

NUS researchers develop self-healing electronic skin

Biologics |  News | 0 Comment | 22 Mar, 2019

Scientists from National University of Singapore (NUS) have taken inspiration from underwater invertebrates like jellyfish to create an electronic skin with similar functionality. Just lik...Read more

Fujifilm to acquire Biogen in a $890 M deal

Biologics |  News | 0 Comment | 13 Mar, 2019

FUJIFILM Corporation ("Fujifilm") announced that it has entered into an agreement to acquire Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hiller...Read more

Ambrx, BeiGene to develop next-generation biologics

Biologics |  News | 0 Comment | 08 Mar, 2019

Ambrx Inc., a clinical-stage biopharmaceutical company focused on the development of innovative protein therapeutics and BeiGene, Ltd., a commercialstage biopharmaceutical company focused o...Read more

Study: Inflammation in the brain enhances the side-effects of hypnotic medication

Biologics |  News | 0 Comment | 06 Mar, 2019

In a study recently published in the European Journal of Pharmacology researchers at Okayama University show how the presence of inflammation in the brain can increase its sensiti...Read more

Duke-NUS team reveals unknown mechanisms of zika infection

Biologics |  News | 0 Comment | 05 Mar, 2019

Researchers at Duke-NUS Medical School and their colleagues have identified a surprising interaction between dengue and Zika viruses that sheds lights on the significant fetal brain abnorma...Read more

Data sharing uncovers five new risk genes for Alzheimer’s disease

Biologics |  News | 0 Comment | 04 Mar, 2019

Analysis of genetic data from more than 94,000 individuals has revealed five new risk genes for Alzheimer’s disease, and confirmed 20 known others. An international team of researche...Read more

Adagene to evaluate dynamic precision library platform with Celgene

Biologics |  Regulatory | 0 Comment | 04 Mar, 2019

China based Adagene, Inc., an innovative antibody discovery and engineering company, has announced a multi-target platform evaluation with Celgene Corporation. Under the terms of the agreem...Read more